Compare · CSTL vs UNH
CSTL vs UNH
Side-by-side comparison of Castle Biosciences Inc. (CSTL) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CSTL and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $371.00B, about 590.9x CSTL ($627.8M).
- Over the past year, CSTL is up 7.3% and UNH is up 32.8% - UNH leads by 25.4 points.
- CSTL has been more active in the news (18 items in the past 4 weeks vs 9 for UNH).
- UNH has more recent analyst coverage (25 ratings vs 5 for CSTL).
- Company
- Castle Biosciences Inc.
- UnitedHealth Group Incorporated
- Price
- $20.68-1.43%
- $408.49+0.79%
- Market cap
- $627.8M
- $371.00B
- 1M return
- +14.13%
- +1.86%
- 1Y return
- +7.32%
- +32.75%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 18
- 9
- Recent ratings
- 5
- 25
Castle Biosciences Inc.
Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify high-risk patients with stage I and II melanomas based on biological information from 31 genes within their tumor tissue. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma, a proprietary GEP test for suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest CSTL
- Pres. & Chief Exec. Officer Maetzold Derek J exercised 6,214 shares at a strike of $2.39 and sold $205,149 worth of shares (9,836 units at $20.86) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Castle Biosciences Inc.
- SEC Form 4 filed by Director Olson Tiffany
- SEC Form 4 filed by Director Goldberg Ellen
- SEC Form 4 filed by Director Harrison Miles
- SEC Form 4 filed by Director Cotton Rodney
- SEC Form 4 filed by Director Caple Kim
- SEC Form 4 filed by Director Bradbury Daniel
- SEC Form 4 filed by Director Cole G Bradley
- Castle Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest UNH
- SEC Form 11-K filed by UnitedHealth Group Incorporated
- UnitedHealth Group Announces Earnings Release Date
- Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 687 shares, decreasing direct ownership by 4% to 16,914 units (SEC Form 4)
- UnitedHealth Group Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- EVP & Chief Legal Officer Zaetta Christopher R covered exercise/tax liability with 134 shares, decreasing direct ownership by 0.80% to 16,582 units (SEC Form 4)
- Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 204 shares, decreasing direct ownership by 1% to 17,601 units (SEC Form 4)
- UnitedHealth upgraded by BofA Securities with a new price target
- UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
- UnitedHealthcare Eliminates Nearly Two-Thirds of Prior Authorization Requirements for Pediatric Care
- UnitedHealthcare Community Plan of D.C. Earns NCQA LTSS Distinction